Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for right ventricular dysfunction in adults with tetralogy of Fallot
2013-002091-41Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tetralogy of Fallot (TOF) comparing Losartan with Placebo (2 arms). Primary endpoint: Change in right ventricular ejection fraction. Started Nov 2013; status: active.
02
Drugs
losartan
03
Conditions
tetralogy of Fallot (TOF)
Beyond the preview
Go deeper on 2013-002091-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002091-41.